+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Mg Alloy Vascular Scaffold Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125691
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Mg Alloy Vascular Scaffold Market is projected to reach USD 247.46 Million in 2026. It is expected to continue growing at a CAGR of 15.52%, reaching USD 583.76 Million by 2032.

Magnesium-Alloy Vascular Scaffolds: Executive Overview

Magnesium-alloy vascular scaffolds are bioresorbable devices designed to provide temporary vessel support and gradually dissolve after healing. Their development reflects efforts to reduce the long-term presence of permanent implants while maintaining sufficient radial strength, controlled degradation, and favorable biological performance. Clinical translation depends on scaffold design, alloy composition, coating technology, deployment systems, and evidence demonstrating safety and effectiveness in appropriate patient populations.

Bioresorption and Device Design Are Reshaping Vascular Intervention

The field is being shaped by the need to balance mechanical support with predictable resorption. Faster degradation can reduce the duration of foreign-body exposure but may compromise structural integrity, while slower degradation can extend support but delay restoration of vessel function. Key technical priorities include improved corrosion control, reduced thrombogenicity, optimized strut geometry, radiopacity, deliverability, and manufacturing consistency. Regulatory expectations are also encouraging more rigorous evidence on late outcomes, imaging, and post-implantation monitoring.

Artificial Intelligence Supports Development, Selection, and Follow-Up

Artificial intelligence can contribute across the scaffold lifecycle without replacing clinical validation. Machine-learning tools may assist with computational modeling of degradation, finite-element assessment of vessel-device interactions, image analysis, patient-risk stratification, and identification of anatomical factors associated with restenosis or thrombosis. In manufacturing, data-driven inspection can help identify dimensional and surface irregularities. These applications require representative datasets, transparent validation, cybersecurity safeguards, and human oversight because errors in device assessment or clinical decision support may have serious consequences.

Regional Insights: Regulation, Infrastructure, and Clinical Practice Shape Adoption

North America combines advanced interventional infrastructure with demanding regulatory and clinical-evidence requirements. Europe emphasizes conformity assessment, post-market surveillance, and evidence of clinical benefit within evolving medical-device frameworks. Asia-Pacific is supported by substantial hospital capacity, device engineering expertise, and growing interest in locally developed technologies, although regulatory pathways differ widely. Latin America presents opportunities where cardiovascular intervention is expanding, while reimbursement and access remain important considerations. The Middle East is developing specialized cardiac-care capabilities, particularly in major urban centers. Africa shows highly varied access to catheterization services, specialist expertise, and follow-up care, making infrastructure and training central to responsible implementation.

Group Insights: Trade, Regulation, and Security Alliances Have Indirect Effects

ASEAN countries differ in regulatory maturity, procurement systems, and specialist capacity, so regional harmonization and clinician training can support more consistent adoption. BRICS members represent diverse manufacturing, research, and healthcare environments, with collaboration potential alongside differing approval and reimbursement processes. The European Union benefits from regulatory coordination but continues to require robust clinical documentation and surveillance. G7 countries generally have strong research ecosystems, sophisticated cardiovascular services, and high expectations for evidence quality. GCC health systems often concentrate advanced care in leading hospitals, while NATO members span multiple regulatory and procurement environments; in both groups, supply resilience and clinical interoperability may influence device deployment.

Country Insights: National Evidence and Health-System Capacity Remain Decisive

Australia and Canada pair advanced clinical services with centralized or coordinated approval and reimbursement considerations. Brazil and Mexico have large and diverse healthcare systems in which specialist access, procurement, and affordability can vary by region. China, India, Japan, and South Korea combine substantial cardiovascular-care demand with active medical-device development, though regulatory pathways and clinical adoption practices differ. France, Germany, Italy, Spain, and the United Kingdom maintain experienced interventional cardiology communities, with adoption influenced by clinical guidelines, health-technology assessment, and hospital purchasing processes. Russia’s implementation environment is shaped by domestic manufacturing capacity, regulatory conditions, and access to specialized equipment and follow-up services. Across all countries, appropriate patient selection and longitudinal monitoring are essential.

Action Priorities for Leaders: Prove Safety, Control Degradation, and Build Access

Industry leaders should prioritize alloy and coating research that produces reproducible degradation behavior, then connect bench testing with clinically meaningful endpoints. Development programs should include comparative trials, standardized imaging protocols, long-term follow-up, and transparent reporting of adverse events. Manufacturers and healthcare providers should establish quality systems capable of detecting subtle production variability and should plan clinician training around implantation technique and patient surveillance. Partnerships with hospitals, regulators, payers, and local distributors can clarify evidence requirements and access barriers in each geography. Responsible use of artificial intelligence should focus on validated tools with explainable outputs, strong data governance, and clear accountability.

Research Methodology: Evidence-Based Review of Technology and Adoption Conditions

This executive summary uses a structured review framework covering device science, vascular intervention practice, regulatory considerations, clinical evidence, manufacturing requirements, healthcare infrastructure, and digital technologies. Findings are synthesized from established medical and engineering knowledge, peer-reviewed research themes, regulatory principles, and publicly documented health-system characteristics. Regional, group, and country observations are presented qualitatively and avoid unsupported numerical claims. Interpretations should be refreshed as clinical trial results, regulatory decisions, reimbursement policies, and post-market safety evidence develop.

Conclusion: Clinical Validation Will Determine the Role of Bioresorbable Scaffolds

Magnesium-alloy vascular scaffolds offer a technically compelling approach to temporary vessel support, but their value depends on achieving a reliable balance between mechanical performance, degradation, deliverability, and long-term clinical outcomes. Progress will require disciplined materials engineering, robust clinical evidence, consistent manufacturing, and health-system readiness. Artificial intelligence can improve development and monitoring when deployed with appropriate safeguards. Leaders that combine scientific rigor with transparent surveillance and region-specific implementation planning will be best positioned to advance the technology responsibly.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Mg Alloy Vascular Scaffold Market, by Scaffold Type
7.1. Introduction
7.2. Bare
7.3. Bioactive
7.4. Drug Eluting
7.4.1. Biolimus Eluting
7.4.2. Everolimus Eluting
7.4.3. Sirolimus Eluting
8. Mg Alloy Vascular Scaffold Market, by Coating
8.1. Introduction
8.2. Non Coated
8.3. Polymer Coated
8.3.1. Biodegradable Polymer
8.3.2. Durable Polymer
9. Mg Alloy Vascular Scaffold Market, by Deployment Mechanism
9.1. Introduction
9.2. Balloon Expandable
9.3. Self Expanding
10. Mg Alloy Vascular Scaffold Market, by Application
10.1. Introduction
10.2. Coronary
10.2.1. Acute Myocardial Infarction
10.2.2. Stable Angina
10.3. Neurovascular
10.3.1. Aneurysm
10.3.2. Ischemic Stroke
10.4. Peripheral
10.4.1. Lower Limb Artery
10.4.2. Renal Artery
11. Mg Alloy Vascular Scaffold Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cardiac Catheterization Labs
11.4. Hospitals
12. Mg Alloy Vascular Scaffold Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Mg Alloy Vascular Scaffold Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Mg Alloy Vascular Scaffold Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AmsinoMed Medical Co., Ltd
16.2. Arterial Remodeling Technologies, Inc.
16.3. Biotronik SE & Co. KG
16.4. Elixir Medical Corporation
16.5. FY MedTech
16.6. Magnesium Elektron Ltd.
16.7. Q3 Medical Devices
16.8. QualiMed, Inc.
16.9. Shanghai Pulin Medical Technology Co., Ltd.
16.10. SINOMED Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Mg Alloy Vascular Scaffold Market, Years Considered for the Study
FIGURE 2. Global Mg Alloy Vascular Scaffold Market, Research Design
FIGURE 3. Global Mg Alloy Vascular Scaffold Market, Research Framework
FIGURE 4. Global Mg Alloy Vascular Scaffold Market, Data Triangulation
FIGURE 5. Global Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2025 vs 2032 (%)
FIGURE 7. Global Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Mg Alloy Vascular Scaffold Market Size, by Coating, 2025 vs 2032 (%)
FIGURE 9. Global Mg Alloy Vascular Scaffold Market Size, by Coating, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2025 vs 2032 (%)
FIGURE 11. Global Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Mg Alloy Vascular Scaffold Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Mg Alloy Vascular Scaffold Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Mg Alloy Vascular Scaffold Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Mg Alloy Vascular Scaffold Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Mg Alloy Vascular Scaffold Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Mg Alloy Vascular Scaffold Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Mg Alloy Vascular Scaffold Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Mg Alloy Vascular Scaffold Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Mg Alloy Vascular Scaffold Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Mg Alloy Vascular Scaffold Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Mg Alloy Vascular Scaffold Market Segmentation & Coverage
TABLE 2. Global Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 3. Global Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 4. Global Bare Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bare Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bare Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Bioactive Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Bioactive Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Bioactive Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Drug Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Drug Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Drug Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Biolimus Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Biolimus Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Biolimus Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Everolimus Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Everolimus Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Everolimus Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Sirolimus Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Sirolimus Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Sirolimus Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 23. Global Non Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Non Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Non Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Polymer Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Polymer Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Polymer Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Biodegradable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Biodegradable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Biodegradable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Durable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Durable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Durable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 36. Global Balloon Expandable Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Balloon Expandable Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Balloon Expandable Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Self Expanding Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Self Expanding Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Self Expanding Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 43. Global Coronary Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Coronary Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Coronary Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Acute Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Acute Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Acute Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Stable Angina Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Stable Angina Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Stable Angina Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Neurovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Neurovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Neurovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Aneurysm Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Aneurysm Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Aneurysm Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Ischemic Stroke Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Ischemic Stroke Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Ischemic Stroke Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Peripheral Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Peripheral Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Peripheral Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Lower Limb Artery Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Lower Limb Artery Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Lower Limb Artery Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Renal Artery Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Renal Artery Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Renal Artery Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Cardiac Catheterization Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Cardiac Catheterization Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Cardiac Catheterization Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Mg Alloy Vascular Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. North America Mg Alloy Vascular Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. North America Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 94. North America Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 95. North America Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 96. North America Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 97. North America Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 98. North America Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. North America Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 100. North America Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 101. North America Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 102. North America Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Latin America Mg Alloy Vascular Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Latin America Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 105. Latin America Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 106. Latin America Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 107. Latin America Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 108. Latin America Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 109. Latin America Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Latin America Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 111. Latin America Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 112. Latin America Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 113. Latin America Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Europe Mg Alloy Vascular Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Europe Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 116. Europe Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 117. Europe Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 118. Europe Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 119. Europe Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 120. Europe Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Europe Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 122. Europe Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 123. Europe Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 124. Europe Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. Middle East Mg Alloy Vascular Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Middle East Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 127. Middle East Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 128. Middle East Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 129. Middle East Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 130. Middle East Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 131. Middle East Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Middle East Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 133. Middle East Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 134. Middle East Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 135. Middle East Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. Africa Mg Alloy Vascular Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Africa Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 138. Africa Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 139. Africa Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 140. Africa Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 141. Africa Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 142. Africa Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. Africa Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 144. Africa Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 145. Africa Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 146. Africa Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Global Mg Alloy Vascular Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. ASEAN Mg Alloy Vascular Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. ASEAN Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 150. ASEAN Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 151. ASEAN Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 152. ASEAN Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 153. ASEAN Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 154. ASEAN Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. ASEAN Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 156. ASEAN Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 157. ASEAN Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 158. ASEAN Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. GCC Mg Alloy Vascular Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. GCC Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 161. GCC Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 162. GCC Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 163. GCC Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 164. GCC Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 165. GCC Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. GCC Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 167. GCC Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 168. GCC Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 169. GCC Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. European Union Mg Alloy Vascular Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. European Union Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 172. European Union Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 173. European Union Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 174. European Union Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 175. European Union Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 176. European Union Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. European Union Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 178. European Union Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 179. European Union Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 180. European Union Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. BRICS Mg Alloy Vascular Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. BRICS Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 183. BRICS Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 184. BRICS Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 185. BRICS Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 186. BRICS Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 187. BRICS Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. BRICS Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 189. BRICS Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 190. BRICS Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 191. BRICS Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. G7 Mg Alloy Vascular Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. G7 Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 194. G7 Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 195. G7 Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 196. G7 Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 197. G7 Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 198. G7 Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. G7 Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 200. G7 Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 201. G7 Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 202. G7 Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. NATO Mg Alloy Vascular Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. NATO Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 205. NATO Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 206. NATO Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 207. NATO Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 208. NATO Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 209. NATO Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. NATO Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 211. NATO Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 212. NATO Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 213. NATO Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Global Mg Alloy Vascular Scaffold Market Size, by Country, 2017-2032 (USD Million)
TABLE 215. United States Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 216. United States Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 217. United States Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 218. United States Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 219. United States Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 220. United States Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 221. United States Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. United States Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 223. United States Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 224. United States Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 225. United States Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Canada Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 227. Canada Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 228. Canada Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 229. Canada Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 230. Canada Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 231. Canada Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 232. Canada Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Canada Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 234. Canada Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 235. Canada Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 236. Canada Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Mexico Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 238. Mexico Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 239. Mexico Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 240. Mexico Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 241. Mexico Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 242. Mexico Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 243. Mexico Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Mexico Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 245. Mexico Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 246. Mexico Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 247. Mexico Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Brazil Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 249. Brazil Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 250. Brazil Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 251. Brazil Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 252. Brazil Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 253. Brazil Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 254. Brazil Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. Brazil Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 256. Brazil Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 257. Brazil Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 258. Brazil Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. United Kingdom Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 260. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 261. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 262. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 263. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 264. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 265. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 267. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 268. United Kingdom Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 269. United Kingdom Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Germany Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 271. Germany Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 272. Germany Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 273. Germany Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 274. Germany Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 275. Germany Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 276. Germany Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. Germany Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 278. Germany Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 279. Germany Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 280. Germany Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. France Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 282. France Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 283. France Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 284. France Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 285. France Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 286. France Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 287. France Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. France Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 289. France Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 290. France Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 291. France Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Russia Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 293. Russia Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 294. Russia Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 295. Russia Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 296. Russia Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 297. Russia Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 298. Russia Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. Russia Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 300. Russia Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 301. Russia Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 302. Russia Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. Italy Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 304. Italy Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 305. Italy Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 306. Italy Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 307. Italy Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 308. Italy Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 309. Italy Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 310. Italy Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 311. Italy Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 312. Italy Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 313. Italy Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. Spain Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 315. Spain Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 316. Spain Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 317. Spain Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 318. Spain Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 319. Spain Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 320. Spain Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. Spain Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 322. Spain Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 323. Spain Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 324. Spain Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 325. China Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 326. China Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 327. China Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 328. China Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 329. China Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 330. China Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 331. China Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 332. China Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 333. China Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 334. China Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 335. China Mg Alloy Vascular Scaffold Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. India Mg Alloy Vascular Scaffold Market Size, 2017-2032 (USD Million)
TABLE 337. India Mg Alloy Vascular Scaffold Market Size, by Scaffold Type, 2017-2032 (USD Million)
TABLE 338. India Mg Alloy Vascular Scaffold Market Size, by Drug Eluting, 2017-2032 (USD Million)
TABLE 339. India Mg Alloy Vascular Scaffold Market Size, by Coating, 2017-2032 (USD Million)
TABLE 340. India Mg Alloy Vascular Scaffold Market Size, by Polymer Coated, 2017-2032 (USD Million)
TABLE 341. India Mg Alloy Vascular Scaffold Market Size, by Deployment Mechanism, 2017-2032 (USD Million)
TABLE 342. India Mg Alloy Vascular Scaffold Market Size, by Application, 2017-2032 (USD Million)
TABLE 343. India Mg Alloy Vascular Scaffold Market Size, by Coronary, 2017-2032 (USD Million)
TABLE 344. India Mg Alloy Vascular Scaffold Market Size, by Neurovascular, 2017-2032 (USD Million)
TABLE 345. India Mg Alloy Vascular Scaffold Market Size, by Peripheral, 2017-2032 (USD Million)
TABLE 346. Indi

Companies Mentioned

  • AmsinoMed Medical Co., Ltd
  • Arterial Remodeling Technologies, Inc.
  • Biotronik SE & Co. KG
  • Elixir Medical Corporation
  • FY MedTech
  • Magnesium Elektron Ltd.
  • Q3 Medical Devices
  • QualiMed, Inc.
  • Shanghai Pulin Medical Technology Co., Ltd.
  • SINOMED Co., Ltd.